Methods for forming protected organoboronic acids

US9353131B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9353131-B2
Application numberUS-201314035408-A
CountryUS
Kind codeB2
Filing dateSep 24, 2013
Priority dateFeb 18, 2010
Publication dateMay 31, 2016
Grant dateMay 31, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described are methods of forming protected boronic acids that provide in a manner that is straightforward, scalable, and cost-effective a wide variety of building blocks, such as building blocks containing complex and/or pharmaceutically important structures, and/or provide simple or complex protected organoboronic acid building blocks. A first method includes reacting an imino-di-carboxylic acid and an organoboronate salt. A second method includes reacting a N-substituted morpholine dione and an organoboronic acid.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of forming a protected boronic acid, comprising: reacting in a reaction mixture a N-substituted morpholine dione, and an organoboronic acid represented by formula (XII): R 1 —B(OH) 2   (XII), wherein R 1 is an organic group, and the reaction mixture further comprises a polar aprotic solvent; and thereby forming a protected organoboronic acid represented by formula (III) in the reaction mixture:  where R 10 represents an organic group, and R 11 , R 12 , R 13 and R 14 independently are selected from the group consisting of a hydrogen group and an organic group. 2. The method of claim 1 , wherein R 1 is an alkyl group, a heteroalkyl group, an alkenyl group, a heteroalkenyl group, an alkynyl group, a heteroalkynyl group, an aryl group, a heteroaryl group, or a combination of at least two of these groups. 3. The method of claim 1 , wherein R 1 is represented by formula (IV): Y—R 5 —(R 6 ) m —  (IV), wherein Y is a halogen group or a pseudohalogen group; R 5 is an aryl group or a heteroaryl group; R 6 is an alkyl group, a heteroalkyl group, an alkenyl group, a heteroalkenyl group, an alkynyl group, a heteroalkynyl group, an aryl group, a heteroaryl group, or a combination of at least two of these groups; and m is 0 or 1. 4. The method of claim 3 , wherein R 5 is a heteroaryl group. 5. The method of claim 1 , wherein R 1 is a heterocyclic group, an alkynyl group or an alkenyl group. 6. The method of claim 5 , wherein said heterocyclic group is selected from the group consisting of pyridine, indole, isoindole, indazole, purine, indolizidine, quinoline, isoquinoline, quinazoline, pteridine, quinolizidine, pyrrole, pyrazine, pyridazine, pyrimidine, imidazole, pyrasole, isoxazole, oxazole, thiazole, benzthiazole, furan, benzofuran, thiophene and benzothiophene. 7. The method of claim 1 , wherein R 1 is a 2-heterocyclic group selected from the group consisting of 2-pyridyl, 2-indolyl, 2-isoindolyl, 2-indazolyl, 2-purinyl, 2-indolizidinyl, 2-quinolinyl, 2-isoquinolinyl, 2-quinazolinyl, 2-pteridinyl, 2-quinolizidinyl, 2-pyrrolyl, 2-pyrazinyl, 2-pyridazinyl, 2-pyrimidinyl, 2-imidazolyl, 2-pyrasolyl, 2-isoxazolyl, 2-oxazolyl, 2-thiazolyl, 2-benzthiazolyl, 2-furyl, 2-benzofuryl, 2-thiophenyl, and 2-benzthiophenyl. 8. The method of claim 1 , wherein R 10 is methyl, and each of R 11 , R 12 , R 13 and R 14 is hydrogen. 9. The method of claim 1 , wherein the polar aprotic solvent is selected from the group consisting of tetrahydrofuran (THF), dioxane, acetonitrile, dimethyl formamide (DMF), toluene and xylene. 10. The method of claim 1 , wherein the polar aprotic solvent is THF. 11. The method of claim 1 , wherein the reaction mixture is maintained at a temperature of from 40° C. to 100° C.

Assignees

Inventors

Classifications

  • C07F5/025Primary

    Boronic and borinic acid compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9353131B2 cover?
Described are methods of forming protected boronic acids that provide in a manner that is straightforward, scalable, and cost-effective a wide variety of building blocks, such as building blocks containing complex and/or pharmaceutically important structures, and/or provide simple or complex protected organoboronic acid building blocks. A first method includes reacting an imino-di-carboxylic ac…
Who is the assignee on this patent?
Burke Martin D, Dick Graham R, Knapp David M, and 3 more
What technology area does this patent fall under?
Primary CPC classification C07F5/025. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).